3Masexi A. Inflammation, atherosclerosis, and ischemie events-exploring the hidden side of the moon[l].N Engl J Med, 1997,336:1014-1016.
4Kuller LH,Tracy RP, Shaten J, et al. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study[J]. Am J Epidemiol, 1996,144:537-547.
5Anderson JL, Carlquist JF, Muhlestein JB, et al. Evaluation of C-reactive protein, an inflammation marker, and infections serology as risk factors for coronary artery disease and myocardial infaretion[J]. J Am Coll Cardiol,1998,32:35-41.
6Rus H, Niculescu FI. Inflammation, aspirin, and the risk of cardiovascular disease[J]. N Engl J Med,1997,337:423.
7Torzewski J, Torzewski M, Bowyer DE, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries[J]. Arterioscler Thromb Vase Bid, 1998,18:1386-1392.
8Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease[J]. Circulation,2001,103:1813-1818.
9Haverkate F, Thompson SG, Pyke SDM, et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina [J]. Lancet, 1997,349:462-466.
10Ridker PM, Cushman M, Stampfer MJ, et al Inflammation, aspirin, and the risk of cardiovascular disease in apparently health men[J]. N Engl J Med, 1997,336:973-979.
二级参考文献3
1US Departmentof Healthand Human Services Monograph，1996年，30页
